| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.80B | 37.47B | 37.12B | 34.17B | 28.28B | 27.94B |
| Gross Profit | 16.22B | 16.39B | 15.78B | 14.09B | 11.21B | 11.50B |
| EBITDA | 4.21B | 4.82B | 4.58B | 3.71B | 2.07B | 3.13B |
| Net Income | 2.27B | 2.95B | 3.46B | 2.57B | 1.09B | 1.74B |
Balance Sheet | ||||||
| Total Assets | 73.86B | 73.89B | 73.16B | 67.16B | 63.37B | 61.67B |
| Cash, Cash Equivalents and Short-Term Investments | 27.60B | 27.10B | 28.44B | 29.40B | 27.08B | 26.63B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 7.14B | 6.53B | 7.41B | 6.71B | 5.63B | 5.15B |
| Stockholders Equity | 66.72B | 67.36B | 65.75B | 60.45B | 57.74B | 56.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 945.00M | 615.00M | 2.94B | 1.59B | 1.80B |
| Operating Cash Flow | 0.00 | 2.90B | 2.48B | 3.63B | 2.22B | 3.05B |
| Investing Cash Flow | 0.00 | -3.05B | -3.95B | 2.27B | -3.57B | 651.00M |
| Financing Cash Flow | 0.00 | -1.39B | -1.12B | -718.00M | -717.00M | -1.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥42.93B | 71.35 | ― | 4.43% | 0.63% | -24.87% | |
79 Outperform | ¥36.50B | 310.64 | ― | 2.26% | 20.13% | 33.43% | |
70 Outperform | ¥41.62B | 14.45 | ― | 2.93% | -0.90% | -13.24% | |
70 Outperform | ¥213.90B | 6.34 | 12.24% | 2.31% | -2.36% | -61.50% | |
68 Neutral | ¥27.51B | 9.33 | 14.95% | 0.77% | 6.43% | 368.06% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | ¥5.79B | 5.26 | ― | 3.54% | 19.28% | ― |